Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

79 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Treatment of chronic granulomatous disease with myeloablative conditioning and an unmodified hemopoietic allograft: a survey of the European experience, 1985-2000.
Seger RA, Gungor T, Belohradsky BH, Blanche S, Bordigoni P, Di Bartolomeo P, Flood T, Landais P, Müller S, Ozsahin H, Passwell JH, Porta F, Slavin S, Wulffraat N, Zintl F, Nagler A, Cant A, Fischer A. Seger RA, et al. Among authors: passwell jh. Blood. 2002 Dec 15;100(13):4344-50. doi: 10.1182/blood-2002-02-0583. Epub 2002 Aug 8. Blood. 2002. PMID: 12393596 Free article. Review.
Engraftment and differentiation of human metanephroi into functional mature nephrons after transplantation into mice is accompanied by a profile of gene expression similar to normal human kidney development.
Dekel B, Amariglio N, Kaminski N, Schwartz A, Goshen E, Arditti FD, Tsarfaty I, Passwell JH, Reisner Y, Rechavi G. Dekel B, et al. Among authors: passwell jh. J Am Soc Nephrol. 2002 Apr;13(4):977-990. doi: 10.1681/ASN.V134977. J Am Soc Nephrol. 2002. PMID: 11912257
Human and porcine early kidney precursors as a new source for transplantation.
Dekel B, Burakova T, Arditti FD, Reich-Zeliger S, Milstein O, Aviel-Ronen S, Rechavi G, Friedman N, Kaminski N, Passwell JH, Reisner Y. Dekel B, et al. Among authors: passwell jh. Nat Med. 2003 Jan;9(1):53-60. doi: 10.1038/nm812. Epub 2002 Dec 23. Nat Med. 2003. PMID: 12496960
Erratum to 'Age-related efficacy of Shigella O-specific polysaccharide conjugates in 1-4-year-old Israeli children' [Vaccine 28 (2010) 2231-2235].
Passwell JH, Ashkenazi S, Banet-Levi Y, Ramon-Saraf R, Farzam N, Lerner-Geva L, Even-Nir H, Yerushalmi B, Chu C, Shiloach J, Robbins JB, Schneerson R; Israeli Shigella Study Group. Passwell JH, et al. Vaccine. 2019 Aug 23;37(36):5504. doi: 10.1016/j.vaccine.2019.07.065. Epub 2019 Aug 1. Vaccine. 2019. PMID: 31378536 Free PMC article. No abstract available.
Age-related efficacy of Shigella O-specific polysaccharide conjugates in 1-4-year-old Israeli children.
Passwell JH, Ashkenazi S, Banet-Levi Y, Ramon-Saraf R, Farzam N, Lerner-Geva L, Even-Nir H, Yerushalmi B, Chu C, Shiloach J, Robbins JB, Schneerson R; Israeli Shigella Study Group. Passwell JH, et al. Vaccine. 2010 Mar 2;28(10):2231-2235. doi: 10.1016/j.vaccine.2009.12.050. Epub 2010 Jan 5. Vaccine. 2010. PMID: 20056180 Free PMC article. Clinical Trial.
O-specific [corrected] polysaccharide conjugate vaccine-induced [corrected] antibodies prevent invasion of Shigella into Caco-2 cells and may be curative.
Chowers Y, Kirschner J, Keller N, Barshack I, Bar-Meir S, Ashkenazi S, Schneerson R, Robbins J, Passwell JH. Chowers Y, et al. Among authors: passwell jh. Proc Natl Acad Sci U S A. 2007 Feb 13;104(7):2396-401. doi: 10.1073/pnas.0610833104. Epub 2007 Feb 7. Proc Natl Acad Sci U S A. 2007. PMID: 17287349 Free PMC article. Clinical Trial.
79 results